← Oncology Approval Tracker

FDA DECISION ·

Xeloda + combination chemotherapy

capecitabine with combination chemotherapy · Genentech

FDA approvalNew or expanded indicationPancreatic cancer
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

Adjuvant use as a component of combination chemotherapy in adults with pancreatic adenocarcinoma.

LAMPGEN ANALYSIS

Why it matters

The decision formalizes an adjuvant pancreatic cancer use for an established oral therapy.

What research teams should watch

Link the resection and pathology records to adjuvant treatment dates and monitor oral adherence.

PRIMARY RECORDS

Sources